Low AMH indicates a low risk of ovarian response and requires an increase in the dosage of ovulation promoting drugs; High AMH signals the risk of ovarian hyperstimulation syndrome (OHSS) and requires adjustments to the treatment plan to reduce complications.5.AMH therapy has been proven effective in the field of tumor fertility to prevent the loss of primordial follicles observed during chemotherapy treatment, particularly through exposure to alkylating agents [40]. This evidence concerns the gene AMH and ovarian hyperstimulation syndrome.